FEED
ENvue Medical, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- B Jan 14 1 insider buy $640.8K at $2.67
- S Feb 2 1 insider sell $6.3K at $3.05
- R Jul 10 ENvue Medical received a delisting notice from Nasdaq on July 10, 20…
- R Aug 10 ENvue Medical filed a universal shelf registration statement to sell…
- R Aug 12 ENvue Medical entered into a $50M committed equity facility (ELOC) w…
- E Aug 31 Trading halt: Trading Halt: FEED — T1 (News Pending)
- R Sep 4 ENvue Medical's S-3 shelf registration (File No. 333-298188) became…
- X Sep 30 Short interest jumps 148.5% to 40.0K
Signal stack
Where each data set points today.
- InsidersBULLISH
1 insider bought $640.8K. 1 insider sold $6.3K.
- InstitutionsMIXED
Q2 2026: 0 added (0 new), 1 trimmed or exited.
- TrendDOWNTREND
88% below its 50-day average. New closing low $0.1820 on Oct 23.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | TRIM | $8.0K |
| UBS Group AG | TRIM | $57.00 |
| UBS Group AG | ADD | $139.00 |
| BANK OF AMERICA CORP /DE/ | ADD | $18.00 |
| UBS Group AG | DOUBLED | $24.3K |
| BANK OF AMERICA CORP /DE/ | ADD | $19.00 |
| CITADEL ADVISORS LLC | ADD | $14.6K |
| BANK OF AMERICA CORP /DE/ | ADD | $15.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 15, 2026 | Glibert Christian Michael | OTHER | 0 sh |
| Feb 2, 2026 | BANK OF AMERICA CORP /DE/ 10%+ Owner | SELL | $250.10 |
| Feb 2, 2026 | BANK OF AMERICA CORP /DE/ 10%+ Owner | SELL | $307.00 |
| Feb 2, 2026 | BANK OF AMERICA CORP /DE/ 10%+ Owner | SELL | $274.50 |
| Feb 2, 2026 | BANK OF AMERICA CORP /DE/ 10%+ Owner | SELL | $558.15 |
| Feb 2, 2026 | BANK OF AMERICA CORP /DE/ 10%+ Owner | SELL | $6.10 |
| Feb 2, 2026 | BANK OF AMERICA CORP /DE/ 10%+ Owner | SELL | $304.00 |
| Feb 2, 2026 | BANK OF AMERICA CORP /DE/ 10%+ Owner | SELL | $30.50 |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026| Sep 15, 2026 | Volatility Pause | Resumed |
| Sep 15, 2026 | Volatility Pause | Resumed |
| Sep 15, 2026 | Volatility Pause | Resumed |
| Sep 15, 2026 | Volatility Pause | Resumed |
| Aug 31, 2026 | Resumption Scheduled | Resumed |
SecBot reports
8 filings · 2 press releases · 0 bullish · 7 bearish · 1 neutral- BEARISH 8-KOct 14, 2026
ENvue Medical entered into a secured promissory note with Alpha Capital Anstalt for up to…
The secured note grants Alpha Capital a blanket lien on all assets including IP and subsidiary equity, creating senior creditor priority. The Series X amendment's anti-dilution ratchet means any…
- BEARISH EFFECTSep 4, 2026
ENvue Medical's S-3 shelf registration (File No. 333-298188) became effective on September 3…
The shelf effectiveness opens the door for an immediate capital raise, likely at distressed prices. Traders should expect a takedown announcement soon, potentially accompanied by a reverse stock…
- NEUTRAL 8-KAug 31, 2026
ENvue Medical (FEED) filed an 8-K covering amendments to its bylaws (Item 5.03) and other events…
Seek the full filing text for Item 8.01 details, which may contain material corporate developments. Monitor for clarifying press releases or subsequent filings.
- BEARISH 8-KAug 12, 2026
ENvue Medical entered into a $50M committed equity facility (ELOC) with an institutional investor…
Massive dilution risk from the ELOC and potential Series H conversion. Monitor for VWAP purchase notices and shareholder vote on the Series H amendment. The 10% discount pricing will pressure the…
All FEED filing & press-release reports (10)
- 8-K reportOct 14, 2026
- EFFECT reportSep 4, 2026
- 8-K reportAug 31, 2026
- 8-K reportAug 12, 2026
- S-3 reportAug 10, 2026
- 8-K reportJul 10, 2026
- PRESS-RELEASE reportJun 3, 2026
- EFFECT reportMay 29, 2026
- S-3 reportMay 18, 2026
- PRESS-RELEASE reportMay 12, 2026